Low riskFDA DrugClass III

Eugia lidocaine HCl injection recalled for barcode labeling issue

The label wrap on Eugia US LLC lidocaine HCl Injection, USP 2%, 40 mg/2 mL single-dose vials covers the barcode, making it hard to scan. The recall covers 168,300 vials in two lots distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Set aside vials from lots 3LC26029A (exp Feb-2029) and 3LC26031A (exp Mar-2029) with NDC 55150-164-02.
  2. Contact Eugia US LLC for next steps. The notice doesn't say how to get a return or replacement.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
168,300 vials
Illnesses reported
None reported
Manufactured in
279 Princeton Hightstown Rd, East Windsor, NJ, United States
Classification
Class III
Recall number
D-0552-2026

In the FDA's words

Description
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02 Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029 Distribution: US Nationwide. Affected quantity: 168,300 vials
Hazard
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Related topics

Label mix upOtherDrugsSold nationwideMore from FDA Drug